Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|November 25, 2015
Genetics of Behçet's diseaseLaura T Morton, Deva Situnayake, Graham R Wallace
General Hospital Psychiatry|April 2, 2021
Interrelationships between heath utility measurements, disease activity and psychological factors in Behçet's diseasePhilip I Murray, Anisha Sekaran, Hedayat Javidi, et al.
Musculoskeletal Care|October 21, 2010
Breaking communication barriers for RA patients of South Asian origin: the use of a bilingual educational audio CD and linguistically appropriate peer support and educationKanta Kumar, Holly John, Chandrika Gordhan, et al.
Journal of Cardiothoracic Surgery|January 12, 2023
Recurrent endobronchial occlusion and aorto-bronchial fistula formation in Behcet's diseaseNiloy Rahman, Eshan Senanayake, Jorge Mascaro, et al.
Clinical Rheumatology|January 18, 2012
Refractory multisystem sarcoidosis responding to infliximab therapyAdam P Croft, Deva Situnayake, Omer Khair, et al.
Rheumatology (Oxford, England)|October 18, 2014
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 yearsChee-Seng Yee, Li Su, Veronica Toescu, et al.
Rheumatology (Oxford, England)|October 21, 2024
Infliximab vs interferon-α in the treatment of Behçet's syndrome: clinical data from the BIO-BEHÇET'S randomized controlled trialRobert J Moots, Farida Fortune, Richard Jackson, et al.
Rheumatology (Oxford, England)|February 11, 2020
Epidemiology, morbidity and mortality in Behçet's disease: a cohort study using The Health Improvement Network (THIN)Tom Thomas, Joht Singh Chandan, Anuradhaa Subramanian, et al.
Rheumatology and Immunology Research|July 3, 2025
Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trialRobert J Moots, Farida Fortune, Richard Jackson, et al.
The Journal of Rheumatology|February 5, 2005
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritisKarim Raza, Mike Breese, Peter Nightingale, et al.
Pageof 2